Lv3
320 积分 2024-06-17 加入
An updated patent review of GLP-1 receptor agonists (2020-present)
5天前
已完结
Optimizing In Vivo CAR T-cell Engineering for Cancer Immunotherapy
9天前
已完结
De novo design and structure of a peptide–centric TCR mimic binding module
1个月前
已完结
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
1个月前
已完结
Synthetic Site-Specific Antibody–Ligand Conjugates Promote Asialoglycoprotein Receptor-Mediated Degradation of Extracellular Human PCSK9
3个月前
已完结
Zanamivir-Amantadine Conjugate: A Dual-Action Agent with Broad-Spectrum Synergistic Antiviral Efficacy
3个月前
已完结
Respiratory syncytial virus infection and novel interventions
4个月前
已完结
Structure-Guided Design of Potent and Selective Covalent Inhibitors Targeting the SARS-CoV-2 Papain-like Protease
4个月前
已完结
Discovery of Daraxonrasib (RMC-6236), a Potent and Orally Bioavailable RAS(ON) Multi-selective, Noncovalent Tri-complex Inhibitor for the Treatment of Patients with Multiple RAS-Addicted Cancers
5个月前
已完结
皖公网安备34019202002308
